CorMedix (CRMD) Operating Margin (2013 - 2025)

CorMedix (CRMD) reported Operating Margin of 45.97% for Q4 2025, up 452.0% on a YoY basis from 8.33% in Q4 2024, and down 6.64% sequentially from 49.24% in Q3 2025.

CorMedix (CRMD) Operating Margin (2013 - 2025) Analysis & Trends

CorMedix (CRMD) has 12 years of Operating Margin data on file, last reported at 45.97% in Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 452.0% year-over-year to 45.97%; the trailing twelve-month figure through Dec 2025 stood at 48.17% (up 9956.0% YoY), and the FY2025 full-year result was 48.17%, up 9959.0% from the prior year.
  • Operating Margin fell to 45.97% in Q4 2025, from 49.24% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 51.5% in Q1 2025 to a low of 102126.07% in Q3 2022.
  • A 4-year average of 25279.54% and a median of 8169.54% in 2021 frame the typical range for Operating Margin.
  • Peak annual rise in Operating Margin reached 3304022 bps in 2022, while the deepest fall reached 8392529 bps in 2022.
  • Tracing CRMD's Operating Margin over 4 years: stood at 13794.92% in 2021, then sank by 105 bps to 28244.66% in 2022, then soared by 100 bps to 41.45% in 2024, then gained by 11 bps to 45.97% in 2025.
  • Business Quant data shows CRMD's Operating Margin at 45.97% in Q4 2025, 49.24% in Q3 2025, and 49.18% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 45.97%

Historic Data

Download Data
DateValue
Dec 31, 2025 45.97%
Sep 30, 2025 49.24%
Jun 30, 2025 49.18%
Mar 31, 2025 51.50%
Dec 31, 2024 41.45%
Sep 30, 2024 -28.70%
Jun 30, 2024 -1,898.09%
Dec 31, 2022 -28,244.66%
Sep 30, 2022 -102,126.07%
Jun 30, 2022 -38,773.09%
Mar 31, 2022 -92,094.83%
Dec 31, 2021 -13,794.92%
Sep 30, 2021 -22,487.18%
Jun 30, 2021 -71,813.31%
Mar 31, 2021 -8,169.54%
Dec 31, 2020 -10,921.20%
Sep 30, 2020 -7,099.29%
Jun 30, 2020 -54,251.71%
Mar 31, 2020 -7,577.91%
Dec 31, 2019 -21,695.96%